Disease areas:
  • cancer and other tissue growths
  • gut health
  • heart and blood vessels
  • mental health
  • nutrition and metabolism
Last updated:
Author(s):
Jiangming Sun, Yunpeng Wang, Lasse Folkersen, Yan Borné, Inge Amlien, Alfonso Buil, Marju Orho-Melander, Anders D. Børglum, David M. Hougaard, Olle Melander, Gunnar Engström, Thomas Werge, Kasper Lage
Publish date:
6 September 2021
Journal:
Nature Communications
PubMed ID:
34489429

Abstract

A promise of genomics in precision medicine is to provide individualized genetic risk predictions. Polygenic risk scores (PRS), computed by aggregating effects from many genomic variants, have been developed as a useful tool in complex disease research. However, the application of PRS as a tool for predicting an individual’s disease susceptibility in a clinical setting is challenging because PRS typically provide a relative measure of risk evaluated at the level of a group of people but not at individual level. Here, we introduce a machine-learning technique, Mondrian Cross-Conformal Prediction (MCCP), to estimate the confidence bounds of PRS-to-disease-risk prediction. MCCP can report disease status conditional probability value for each individual and give a prediction at a desired error level. Moreover, with a user-defined prediction error rate, MCCP can estimate the proportion of sample (coverage) with a correct prediction.

Related projects

We aim to investigate factors that relate to brain health in midlife and older age. Overall research questions: ? Do factors such as…

Institution:
University of Oslo, Norway

All projects